The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review
Open accessAbstract
There are several bacteria called superbugs that are resistant to multiple antibiotics which can be life threatening specially for critically ill and hospitalized patients. This article provides up-to-date treatment strategies employed against some major superbugs, like methicillin-resistant Staphylococcus aureus , carbapenem-resistant Enterobacteriaceae , vancomycin-resistant Enterococcus , multidrug-resistant Pseudomonas aeruginosa , and multidrug-resistant Escherichia coli . The pathogen-directed therapeutics decrease the toxicity of bacteria by altering their virulence factors by specific processes. On the other hand, the host-directed therapeutics limits these superbugs by modulating immune cells, enhancing host cell functions, and modifying disease pathology. Several new antibiotics against the global priority superbugs are coming to the market or are in the clinical development phase. Medicinal plants possessing potent secondary metabolites can play a key role in the treatment against these superbugs. Nanotechnology has also emerged as a promising option for combatting them. There is urgent need to continuously figure out the best possible treatment strategy against these superbugs as resistance can also be developed against the new and upcoming antibiotics in future. Rational use of antibiotics and maintenance of proper hygiene must be practiced among patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01441 · Cited by 881
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
Pachori, P., Gothalwal, R., & Gandhi, P. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.04.001 · Cited by 620
Crank, C., & O'Driscoll, T. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s54125 · Cited by 505
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
Catalano, A., Iacopetta, D., Ceramella, J., Scumaci, D., Giuzio, F., Saturnino, C., Aquaro, S., Rosano, C., & Sinicropi, M. S. (2022) · Molecules · doi:10.3390/molecules27030616 · Cited by 450
Gemmell, C. G., Edwards, D. I., Fraise, A. P., Gould, F. K., Ridgway, G. L., & Warren, R. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl017 · Cited by 439
Bacterial resistance to antibiotics: Modified target sites
LAMBERT, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.003 · Cited by 424
Brown, A. N., Smith, K., Samuels, T. A., Lu, J., Obare, S. O., & Scott, M. E. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.06513-11 · Cited by 420
New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
Isler, B., Doi, Y., Bonomo, R. A., & Paterson, D. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01110-18 · Cited by 293
Recent Progress in Polymer Research to Tackle Infections and Antimicrobial Resistance
Konai, M. M., Bhattacharjee, B., Ghosh, S., & Haldar, J. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00458 · Cited by 281
The Role of Nanotechnology in Combating Multi-Drug Resistant Bacteria
Singh, R., Smitha, M. S., & Singh, S. P. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2014.9527 · Cited by 265
Qin, H.-L., Liu, J., Fang, W.-Y., Ravindar, L., & Rakesh, K. P. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112245 · Cited by 200
Membrane Permeability and Regulation of Drug “Influx and Efflux” in Enterobacterial Pathogens
Davin-Regli, A., Bolla, J.-M., James, C., Lavigne, J.-P., Chevalier, J., Garnotel, E., Molitor, A., & Pages, J.-M. (2008) · Current Drug Targets · doi:10.2174/138945008785747824 · Cited by 188
Antimicrobial resistance and the role of vaccines
Bloom, D. E., Black, S., Salisbury, D., & Rappuoli, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717157115 · Cited by 175
Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections
Gondil, V. S., Harjai, K., & Chhibber, S. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.11.001 · Cited by 173
Kanj, S. S., Bassetti, M., Kiratisin, P., Rodrigues, C. S., Villegas, M. V., Yu, Y., & van Duin, D. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106633 · Cited by 157
Penicillin binding protein 2a: An overview and a medicinal chemistry perspective
Shalaby, M.-A. W., Dokla, E. M. E., Serya, R. A. T., & Abouzid, K. A. M. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112312 · Cited by 147
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections
Heo, Y. (2021) · Drugs · doi:10.1007/s40265-021-01471-8 · Cited by 139
Bacterial Targets of Antibiotics in Methicillin-Resistant Staphylococcus aureus
Lade, H., & Kim, J.-S. (2021) · Antibiotics · doi:10.3390/antibiotics10040398 · Cited by 134
Dey, D., Ray, R., & Hazra, B. (2013) · Phytotherapy Research · doi:10.1002/ptr.5090 · Cited by 113
Rahman, S., Parvez, M. A. K., Islam, R., & Khan, M. H. (2011) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-10-10 · Cited by 112
Sadiq, M. B., Tärning, J., Cho, T.-Z. A., & Anal, A. K. (2017) · Molecules · doi:10.3390/molecules22010047 · Cited by 108
Abdelhamid, A. G., Esaam, A., & Hazaa, M. M. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.03.004 · Cited by 102
Souza, L. M. D. S., Dibo, M., Puño-Sarmiento, J. J., Seabra, A. B., Medeiros, L. P., Lourenço, I. M., Kobayashi, R. K. T., & Nakazato, G. (2022) · Current Research in Green and Sustainable Chemistry · doi:10.1016/j.crgsc.2022.100303 · Cited by 100
Chawla, M., Verma, J., Gupta, R., & Das, B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.887251 · Cited by 94
Recent advances in antibacterial agents
Kong, Q., & Yang, Y. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127799 · Cited by 87
KHALIL, M. A. E. F., Maghraby, G. M. E., Sonbol, F., Allam, N. G., Ateya, P. S., & Ali, S. S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.648560 · Cited by 83
Hakeam, H. A., Al-Sahli, H., Albabtain, L., Alassaf, S., Duhailib, Z. A., & Althawadi, S. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.079 · Cited by 80
Dharmaratne, M. P. J., Manoraj, A., Thevanesam, V., Ekanayake, A., Kumar, N. S., Liyanapathirana, V. C., Abeyratne, E., & Bandara, B. M. R. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2382-7 · Cited by 72
KHALIL, M. A. E. F., El‐Shanshoury, A. E. R., Alghamdi, M. A., Alsalmi, F. A., Mohamed, S. F., Sun, J., & Ali, S. S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.705673 · Cited by 66
Phan, M., Forde, B. M., Peters, K. M., Sarkar, S., Hancock, S. J., Stanton-Cook, M. J., Zakour, N. L. B., Upton, M., Beatson, S. A., & Schembri, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122369 · Cited by 65
Kaur, B., Gupta, J., Sharma, S., Sharma, D., & Sharma, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.08.199 · Cited by 64
Effects of iron oxide (Fe 3 O 4 ) nanoparticles on Escherichia coli antibiotic‐resistant strains
Gabrielyan, L. S., Hakobyan, L., Hovhannisyan, A. A., & Trchоunian, A. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14214 · Cited by 59
Phloroglucinol and Its Derivatives: Antimicrobial Properties toward Microbial Pathogens
Khan, F., Tabassum, N., Bamunuarachchi, N. I., & Kim, Y. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00532 · Cited by 59
Mehta, J., Rolta, R., & Dev, K. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114589 · Cited by 57
Billamboz, M., Fatima, Z., Hameed, S., & Jawhara, S. (2021) · Microorganisms · doi:10.3390/microorganisms9030634 · Cited by 56
Memar, M. Y., Yekani, M., Ghanbari, H., Shahi, S., Sharifi, S., & Dizaj, S. M. (2020) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2020.1850466 · Cited by 43
Nanoantibiotics to fight multidrug resistant infections by Gram-positive bacteria: hope or reality?
Berini, F., Orlandi, V. T., Gornati, R., Bernardini, G., & Marinelli, F. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.107948 · Cited by 41
Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin
Eraikhuemen, N., Julien, D., Kelly, A., Lindsay, T., & Lazaridis, D. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00378-3 · Cited by 39
Colson, A. R., Morton, A., Årdal, C., Chalkidou, K., Davies, S. C., Garrison, L. P., Jit, M., Laxminarayan, R., Megiddo, I., Morel, C. M., et al. (2021) · Value in Health · doi:10.1016/j.jval.2021.06.002 · Cited by 35
Rohatgi, A., & Gupta, P. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105055 · Cited by 34
Bassetti, M., Puente, F. D., Magnasco, L., & Giacobbe, D. R. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1750595 · Cited by 28
Rolta, R., Goyal, M., Sharma, S., Bharaj, D., Salaria, D., Upadhyay, N. K., Lal, U. R., Dev, K., & Sourirajan, A. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2022.100076 · Cited by 24
Vaz, M. S. M., Simionatto, E., de Souza, G. H. D. A., Fraga, T. L., de Oliveira, G. G., Coutinho, E. J., dos Santos, M. V. O., & Simionatto, S. (2022) · Industrial Crops and Products · doi:10.1016/j.indcrop.2022.115065 · Cited by 24
Verma, A. K., & Kumar, P. (2022) · Journal of Nanotechnology · doi:10.1155/2022/5560244 · Cited by 24
de Andrade, L. F., Apolinário, A. C., Rangel‐Yagui, C. D. O., Stephano, M. A., & Tavares, L. C. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101363 · Cited by 23
Tahmasebi, H., Dehbashi, S., & Arabestani, M. R. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104518 · Cited by 23
de Farias, F. M., Teixeira, L. M., Vallim, D. C., Bastos, M. D. C. D. F., Miguel, M. A. L., & Bonelli, R. R. (2021) · Brazilian Journal of Microbiology · doi:10.1007/s42770-021-00494-3 · Cited by 22
Katahira, E. J., Davidson, S. M., Stevens, D. L., & Bolz, D. D. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000905 · Cited by 21
Zykov, I. N., Frimodt‐Møller, N., Småbrekke, L., Sundsfjord, A., & Samuelsen, Ø. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.11.008 · Cited by 21
Bakthavatchalam, Y. D., Rao, S. V., Isaac, B. T. J., Abi Manesh, S., Nambi, S., Swaminathan, S., Nagvekar, V., Nangia, V., John, P. V., & Veeraraghavan, B. (2019) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_20_34 · Cited by 21
Murugan, M., Rani, K. R. B., Wins, J. A., Ramachandran, G., Guo, F., Mothana, R. A., Noman, O. M., Nasr, F. A., & Ṣiddiqi, M. Z. (2021) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2021.101737 · Cited by 19
Paukner, S., Goldberg, L., Alexander, E. L., Das, A., Heinrich, S., Patel, P., Moran, G. J., Sandrock, C., File, T. M., Vidal, J. E., et al. (2021) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2021.10.021 · Cited by 17
Giacobbe, D. R., Dettori, S., Corcione, S., Vena, A., Sepulcri, C., Maraolo, A. E., Rosa, F. G. D., & Bassetti, M. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s318322 · Cited by 17
Xu, C., Wang, A., Honnen, W. J., Pinter, A., Weston, W., Harness, J. A., Narayanan, A., & Chang, T. L.-Y. (2022) · PubMed · Cited by 13
Rajput, A., Bhamare, K. T., Mukhopadhyay, A., Rastogi, A., Sakshi, & Kumar, M. (2020) · ACS symposium series · doi:10.1021/bk-2020-1374.ch010 · Cited by 11
Fang, H.-Q., Zeng, J., Wang, S., Xiao, W., Chen, F., Li, B., Liu, J., Jin, Z., Liu, Y., & Tang, Y. (2022) · Molecules · doi:10.3390/molecules27030931 · Cited by 11
Jean, S., Lu, M., Ho, M., Ko, W., & Hsueh, P. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106521 · Cited by 10
Huang, D. B., Noviello, S., Balser, B., et al. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.04.004 · Cited by 9
Zhao, M., Chi, Z., Pan, X., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084816 · Cited by 9
Chigorimbo‐Murefu, N. T. L., Potgieter, M. G., Dzanibe, S., Gabazana, Z., Buri, G., Chawla, A., Nleya, B., Olivier, A. J., Harryparsad, R., Calder, B., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.928317 · Cited by 5
Cited by
Antimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,338
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Unveiling the menace: a thorough review of potential pandemic fungal disease
Jafarlou, M. (2024) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2024.1338726 · Cited by 24
Metadata
- Authors
- Parmanik, A., Das, S., Kar, B., Bose, A., Dwivedi, G. R., & Pandey, M. M.
- Venue
- Current Microbiology
- Published
- 2022-11-03
- Volume
- 79
- Issue
- 12
- Pages
- 388-388
- ISSN
- 0343-8651 (ISSN-L)
- 1432-0991
- OpenAlex
- W4308493722
- Cited by
- 277
- References
- 62
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.